ArticleNature communications2021

SARS-CoV-2 neutralizing human recombinant antibodies selected from pre-pandemic healthy donors binding at RBD-ACE2 interface.

Federico Bertoglio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.